3D Cell Culture and 3D Bioprinting Market Report 2023-2033
상품코드:1357211
리서치사:Visiongain
발행일:2023년 10월
페이지 정보:영문 243 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 3D 세포배양 및 3D 바이오프린팅 시장 규모는 2033년까지 17.8%의 CAGR로 성장할 것으로 예측되고 있습니다.
3D 세포 배양 및 바이오 프린팅 기술의 임상 적용이 빠르게 성장하고 있으며, 환자 중심 의료 솔루션의 새로운 시대를 열었습니다. 이식 가능한 조직, 인공 장기 및 개인 맞춤형 이식편은 외과수술에 혁명을 일으켜 보다 안전하고 효과적인 개입을 제공합니다. 또한 이러한 기술은 암, 신경 퇴행성 질환, 심혈관 질환 등 다양한 질병을 연구하고 치료할 수 있는 무한한 잠재력을 가지고 있습니다. 규제기관이 이러한 혁신적인 접근 방식을 점점 더 많이 수용함에 따라 임상 분야에서 시장이 크게 성장할 것으로 예상됩니다.
헬스케어 및 제약 산업이 3D 세포 배양 및 바이오 프린팅 시장의 주요 촉진 산업인 반면, 다른 분야도 큰 잠재력을 보여주고 있습니다. 예를 들어 화장품 및 스킨케어 산업은 효능 테스트를 위해 3D 피부 모델을 활용하여 보다 안전하고 효과적인 제품을 개발할 수 있도록 하고 있습니다. 또한 식품 및 음료 분야에서는 배양육 생산에 3D 바이오프린팅의 가능성을 모색하고 있으며, 기존 축산업에 대한 지속가능한 대안을 제시하고 있습니다. 이러한 용도의 다양화는 시장 범위의 확장을 의미하며, 신규 사업자에게 새로운 매출 기회를 제공합니다.
세계의 3D 세포배양 및 3D 바이오프린팅 시장을 조사했으며, 시장 개요, 시장 성장에 대한 각종 영향요인 분석, 시장 규모의 추이·예측, 각종 구분·지역/주요 국가별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 리포트 개요
제2장 주요 요약
제3장 시장 개요
주요 조사 결과
시장 역학
시장 촉진요인
시장 억제요인
시장 기회
COVID-19의 영향 분석
Porter's Five Forces 분석
PEST 분석
제4장 3D 세포배양 및 3D 바이오프린팅 시장 분석 : 기술별
주요 조사 결과
시장 매력 지수
시장 규모 추산·예측
스캐폴드 기반
스캐폴드 프리
마이크로플루이딕스 기반
자기부상
3D 바이오프린팅
기타
제5장 3D 세포배양 및 3D 바이오프린팅 시장 분석 : 용도별
주요 조사 결과
시장 매력 지수
시장 규모 추산·예측
암·줄기세포 연구
Drug Discovery·독성 시험
조직공학·재생의료
제6장 3D 세포배양 및 3D 바이오프린팅 시장 분석 : 최종사용자별
주요 조사 결과
시장 매력 지수
시장 규모 추산·예측
제약 및 바이오테크놀러지 기업
학술기관
연구소
기타
제7장 3D 세포배양 및 3D 바이오프린팅 시장 분석 : 지역별
주요 조사 결과
시장 규모 추산·예측
제8장 북미의 3D 세포배양 및 3D 바이오프린팅 시장 분석
제9장 유럽의 3D 세포배양 및 3D 바이오프린팅 시장 분석
제10장 아시아태평양의 3D 세포배양 및 3D 바이오프린팅 시장 분석
제11장 라틴아메리카의 3D 세포배양 및 3D 바이오프린팅 시장 분석
제12장 중동 및 아프리카의 3D 세포배양 및 3D 바이오프린팅 시장 분석
제13장 기업 개요
3D Biotek LLC
Aspect Biosystems Ltd.
CELLINK
CN Bio Innovations Ltd.
Corning Incorporated
CYFUSE BIOMEDICAL K.K.
GeSiM
InSphero
Lonza
Merck KGaA
Organovo Holdings Inc.
REPROCELL Inc.
Thermo Fisher Scientific Inc.
ENVISIONTEC
제14장 결론·제안
KSA
영문 목차
영문목차
The global 3D Cell Culture and 3D Bioprinting market is projected to grow at a CAGR of 17.8% by 2033.
“The 3D Cell Culture and 3D Bioprinting Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Bridging the Gap between Bench and Bedside
The clinical applications of 3D cell culture and bioprinting technologies are burgeoning, heralding a new era of patient-centric healthcare solutions. Implantable tissues, artificial organs, and personalized grafts are poised to revolutionize surgical procedures, offering safer and more effective interventions. Moreover, these technologies hold immense potential for the study and treatment of a wide array of diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. With regulatory bodies becoming increasingly receptive to these innovative approaches, the market is primed for substantial growth in the clinical sector.
Beyond Healthcare and Pharmaceuticals
While healthcare and pharmaceutical industries are the primary drivers of the 3D cell culture and bioprinting market, ancillary sectors are also poised to reap substantial benefits. The cosmetics and skincare industry, for instance, is capitalizing on 3D skin models for efficacy testing, enabling the development of safer and more effective products. Additionally, the food and beverage sector is exploring the potential of 3D bioprinting in cultured meat production, offering a sustainable alternative to traditional livestock farming. This diversification of applications signifies a broader market reach and opens up new revenue streams for stakeholders.
What Questions Should You Ask before Buying a Market Research Report?
How is the 3D cell culture and 3D bioprinting market evolving?
What is driving and restraining the 3D cell culture and 3D bioprinting market?
How will each 3D cell culture and 3D bioprinting submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
How will the market shares for each 3D cell culture and 3D bioprinting submarket develop from 2023 to 2033?
What will be the main driver for the overall market from 2023 to 2033?
Will leading 3D cell culture and 3D bioprinting markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
Who are the leading players and what are their prospects over the forecast period?
What are the 3D cell culture and 3D bioprinting projects for these leading companies?
How will the industry evolve during the period between 2023 and 2033? What are the implications of
3D cell culture and 3D bioprinting projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the 3D cell culture and 3D bioprinting market?
Where is the 3D cell culture and 3D bioprinting market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the 3D cell culture and 3D bioprinting market today, and over the next 10 years:
Our 243-page report provides 98 tables and 133 charts/graphs exclusively to you
The report highlights key lucrative areas in the industry so you can target them - NOW
It contains in-depth analysis of global, regional and national sales and growth
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the 3D cell culture and 3D bioprinting market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
You will find original analyses, with business outlooks and developments
Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.
Segments Covered in the Report:
Technology
Scaffold-based
Scaffold-free
Microfluidics-based
Magnetic Levitation
3D Bioprinting
Others
Application
Cancer and Stem Cell Research
Drug Discovery and Toxicology Testing
Tissue Engineering and Regenerative Medicine
End-users
Pharmaceutical & Biotechnology Companies
Academic Institutes
Research Laboratories
Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
MEA
GCC
South Africa
Rest of MEA
The report also includes profiles and for some of the leading companies in the 3D Cell Culture and 3D Bioprinting Market, 2023 to 2033, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth:
Aspect Biosystems Ltd.
CELLINK
CN Bio Innovations Ltd.
Corning Incorporated
CYFUSE BIOMEDICAL K.K
GeSiM
InSphero
Lonza
Merck KGaA
Organovo Holdings Inc.
REPROCELL Inc
Thermo Fisher Scientific Inc
ENVISIONTEC
Overall world revenue for 3D Cell Culture and 3D Bioprinting Market, 2023 to 2033 in terms of value the market will surpass US$2,200 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the “3D Cell Culture and 3D Bioprinting Market, 2023 to 2033” report help you?
In summary, our 240+ page report provides you with the following knowledge:
Revenue forecasts to 2033 for 3D Cell Culture and 3D Bioprinting Market 2023 to 2033, with forecasts for technology, application, and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2033 for five regional and 22 key national markets - See forecasts for the 3D Cell Culture and 3D Bioprinting Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 13 of the major companies involved in the 3D Cell Culture and 3D Bioprinting Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the 3D Cell Culture and 3D Bioprinting Market 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to 3D Cell Culture and 3D Bioprinting Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Demand for Drug Development
3.2.1.2 3D Bioprinting for Organ Transplanting
3.2.1.3 Rising Stem Cell Research Driving Market Growth
3.2.1.4 Use of 3D Cell Culture Model in Cancer Research
3.2.2 Market Restraining Factors
3.2.2.1 Development of Complex Organ Structures
3.2.2.2 Development of Realistic Vascular Networks
3.2.2.3 High Cost and Operational Limitations of Bioprinters
3.2.3 Market Opportunities
3.2.3.1 Development of Biocompatible and Printable Biomaterials
3.2.3.2 Rising Commercialization and Mass Production in 3D Bioprinting
3.2.3.3 Increase in New Product Launches and Collaborations to Offer Lucrative Growth Opportunities
3.2.3.4 Use of Artificial Intelligence in 3D Bioprinting
3.3 COVID-19 Impact Analysis
3.4 Porter's Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 3D Cell Culture and 3D Bioprinting Market Analysis by Technology
4.1 Key Findings
4.2 Technology Segment: Market Attractiveness Index
4.3 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Technology
4.4 Scaffold-based
4.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Scaffold-free
4.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Microfluidics-based
4.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Magnetic Levitation
4.7.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 3D Bioprinting
4.8.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Others
4.9.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.9.2 Market Share by Region, 2023 & 2033 (%)
5 3D Cell Culture and 3D Bioprinting Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Application
5.4 Cancer and Stem Cell Research
5.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Drug Discovery and Toxicology Testing
5.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Tissue Engineering and Regenerative Medicine
5.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.6.2 Market Share by Region, 2023 & 2033 (%)
6 3D Cell Culture and 3D Bioprinting Market Analysis by End-users
6.1 Key Findings
6.2 End-users Segment: Market Attractiveness Index
6.3 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by End-users
6.4 Pharmaceutical & Biotechnology Companies
6.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Academic Institutes
6.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Research Laboratories
6.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Others
6.7.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.7.2 Market Share by Region, 2023 & 2033 (%)
7 3D Cell Culture and 3D Bioprinting Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America 3D Cell Culture and 3D Bioprinting Market Analysis
8.1 Key Findings
8.2 North America 3D Cell Culture and 3D Bioprinting Market Attractiveness Index
8.3 North America 3D Cell Culture and 3D Bioprinting Market by Country, 2023, 2028 & 2033 (US$ Million)
8.4 North America 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Country
8.5 North America 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Technology
8.6 North America 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Application
8.7 North America 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by End-users
8.8 U.S. 3D Cell Culture and 3D Bioprinting Market Analysis
8.9 Canada 3D Cell Culture and 3D Bioprinting Market Analysis
9 Europe 3D Cell Culture and 3D Bioprinting Market Analysis
9.1 Key Findings
9.2 Europe 3D Cell Culture and 3D Bioprinting Market Attractiveness Index
9.3 Europe 3D Cell Culture and 3D Bioprinting Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 Europe 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Country
9.5 Europe 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Technology
9.6 Europe 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Application
9.7 Europe 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by End-users
9.8 Germany 3D Cell Culture and 3D Bioprinting Market Analysis
9.9 UK 3D Cell Culture and 3D Bioprinting Market Analysis
9.10 France 3D Cell Culture and 3D Bioprinting Market Analysis
9.11 Italy 3D Cell Culture and 3D Bioprinting Market Analysis
9.12 Spain 3D Cell Culture and 3D Bioprinting Market Analysis
9.13 Russia 3D Cell Culture and 3D Bioprinting Market Analysis
9.14 Rest of Europe 3D Cell Culture and 3D Bioprinting Market Analysis
10 Asia Pacific 3D Cell Culture and 3D Bioprinting Market Analysis
10.1 Key Findings
10.2 Asia Pacific 3D Cell Culture and 3D Bioprinting Market Attractiveness Index
10.3 Asia Pacific 3D Cell Culture and 3D Bioprinting Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Asia Pacific 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Country
10.5 Asia Pacific 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Technology
10.6 Asia Pacific 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Application
10.7 Asia Pacific 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by End-users
10.8 Japan 3D Cell Culture and 3D Bioprinting Market Analysis
10.9 China 3D Cell Culture and 3D Bioprinting Market Analysis
10.10 India 3D Cell Culture and 3D Bioprinting Market Analysis
10.11 Australia 3D Cell Culture and 3D Bioprinting Market Analysis
10.12 South Korea 3D Cell Culture and 3D Bioprinting Market Analysis
10.13 South-East Asia 3D Cell Culture and 3D Bioprinting Market Analysis
10.14 Rest of Asia Pacific 3D Cell Culture and 3D Bioprinting Market Analysis
11 Latin America 3D Cell Culture and 3D Bioprinting Market Analysis
11.1 Key Findings
11.2 Latin America 3D Cell Culture and 3D Bioprinting Market Attractiveness Index
11.3 Latin America 3D Cell Culture and 3D Bioprinting Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Latin America 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Country
11.5 Latin America 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Technology
11.6 Latin America 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Application
11.7 Latin America 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by End-users
11.8 Brazil 3D Cell Culture and 3D Bioprinting Market Analysis
11.9 Mexico 3D Cell Culture and 3D Bioprinting Market Analysis
11.10 Rest of Latin America 3D Cell Culture and 3D Bioprinting Market Analysis
12 MEA 3D Cell Culture and 3D Bioprinting Market Analysis
12.1 Key Findings
12.2 MEA 3D Cell Culture and 3D Bioprinting Market Attractiveness Index
12.3 MEA 3D Cell Culture and 3D Bioprinting Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 MEA 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Country
12.5 MEA 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Technology
12.6 MEA 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by Application
12.7 MEA 3D Cell Culture and 3D Bioprinting Market Size Estimation and Forecast by End-users
12.8 GCC 3D Cell Culture and 3D Bioprinting Market Analysis
12.9 South Africa 3D Cell Culture and 3D Bioprinting Market Analysis
12.10 Rest of MEA 3D Cell Culture and 3D Bioprinting Market Analysis
13 Company Profiles
13.1 3D Biotek LLC
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Product Benchmarking
13.2 Aspect Biosystems Ltd.
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Product Benchmarking
13.2.4 Strategic Outlook
13.3 CELLINK
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Product Benchmarking
13.3.4 Strategic Outlook
13.4 CN Bio Innovations Ltd.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Product Benchmarking
13.4.4 Strategic Outlook
13.5 Corning Incorporated
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2018-2022
13.5.3.2 R&D, 2018-2022
13.5.4 Product Benchmarking
13.5.5 Strategic Outlook
13.6 CYFUSE BIOMEDICAL K.K.
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.7 GeSiM
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product Benchmarking
13.8 InSphero
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.8.4 Strategic Outlook
13.9 Lonza
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2018-2022
13.9.3.2 Regional Market Shares, 2022
13.9.3.3 R&D, 2018-2022
13.9.4 Product Benchmarking
13.10 Merck KGaA
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2018-2022
13.10.3.2 Regional Market Shares, 2022
13.10.3.3 R&D, 2018-2022
13.10.4 Product Benchmarking
13.11 Organovo Holdings Inc.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
13.11.4 Strategic Outlook
13.12 REPROCELL Inc.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Product Benchmarking
13.13 Thermo Fisher Scientific Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2018-2022
13.13.3.2 Regional Market Shares, 2022
13.13.3.3 R&D, 2018-2022
13.13.4 Product Benchmarking
13.14 ENVISIONTEC
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
List of Tables
Table 1 3D Cell Culture and 3D Bioprinting Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 3D Cell Culture and 3D Bioprinting Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 3 3D Cell Culture and 3D Bioprinting Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 4 3D Cell Culture and 3D Bioprinting Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 5 3D Cell Culture and 3D Bioprinting Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 6 3D Cell Culture and 3D Bioprinting Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
